| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC0354 |
| Trial ID | NCT03029338 |
| Disease | B-Cell Non-Hodgkin's Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CNCT19|inaticabtagene autoleucel |
| Location approved | China |
| Generation | 2nd |
| Phase | Phase1 |
| Recruitment status | Completed |
| Title | CD19 CAR T Cells in Patients With Relapsed or Refractory CD19 Positive B-cell Lymphoma |
| Year | 2017 |
| Country | China |
| Company sponsor | Institute of Hematology & Blood Diseases Hospital |
| Other ID(s) | XH-CD19CART-002 |
| Vector information | |||||||
|
|||||||
| Cohort 1 | |||||||||||||||||||
|
|||||||||||||||||||